Macquarie Group LTD Sage Therapeutics, Inc. Transaction History

Macquarie Group LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $3,002 - $4,024	-93 Reduced 3.41%	2,637 $139,000
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $23,458 - $29,820	-633 Reduced 18.82%	2,730 $116,000
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $67,838 - $96,668	1,685 Added 100.42%	3,363 $149,000
Q2 2021 Aug 13, 2021	SELL	$54.88 - $79.29 $1,207 - $1,744	-22 Reduced 1.29%	1,678 $95,000
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $38,645 - $52,927	-547 Reduced 24.34%	1,700 $127,000
Q2 2020 Aug 11, 2020	BUY	$25.95 - $43.15 $14,194 - $23,603	547 Added 32.18%	2,247 $93,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $550,222 - $1.63 Million	-21,041 Reduced 92.52%	1,700 $49,000
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $658,076 - $763,302	4,169 Added 22.45%	22,741 $4.16 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $19,652 - $36,003	-220 Reduced 1.17%	18,572 $2.95 Million
Q4 2018 Feb 15, 2019	BUY	$81.94 - $139.71 $491,230 - $837,561	5,995 Added 46.85%	18,792 $1.8 Million
Q3 2018 Nov 15, 2018	SELL	$138.11 - $169.04 $97,091 - $118,835	-703 Reduced 5.21%	12,797 $1.81 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $1.5 Million - $1.88 Million	10,676 Added 378.05%	13,500 $2.11 Million
Q1 2018 May 11, 2018	BUY	$152.15 - $192.33 $429,671 - $543,139	2,824 New	2,824 $455,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.